Form CERTNAS - Certification by the Nasdaq Stock Market approving securities for listing:
SEC Accession No. 9999999997-17-006006
Filing Date
2017-05-04
Accepted
2017-05-09 09:20:02
Documents
1
Effectiveness Date
2017-05-04

Document Format Files

Seq Description Document Type Size
1 AUTO-GENERATED PAPER DOCUMENT 9999999997-17-006006.paper CERTNAS 294
  Scanned paper document scanned.pdf   221990
  Complete submission text file 9999999997-17-006006.txt   1421
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

EIN.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CERTNAS | Act: 34 | File No.: 001-37969 | Film No.: 17010479
SIC: 3845 Electromedical & Electrotherapeutic Apparatus